Edgaras Dlugauskas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edgaras Dlugauskas has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Algirdas Utkus
2 shared publicationsRobertas Badaras
2 shared publications- Aiste Lengvenyte
Fondation FondaMental, Créteil, France; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, Centre Hospitalier Universitaire de Montpellier, Institute of Functional Genomics, University of Montpellier, National Centre for Scientific Research, French National Institute of Health and Medical Research, Montpellier, France
1 shared publication Andrius Kaminskas
Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius, Lithuania
1 shared publicationAsta Blazyte
Ulsan National Institute of Science and Technology
1 shared publicationByoung-Chul Kim
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Research Square
Epigenetic signatures of recurrent suicide attempts with cross-ethnic and cross-tissue validation highlight the NEK4-ITIH1 locus
Suicide is a major public health concern, yet objective biological markers for risk assessment remain lacking. Prior blood-based epigenomic studies have largely returned immune-related signals of uncertain specificity to suicidality. Here, we performed differential methylation analysis on whole blood from 69 Korean suicide attempters and 207 matched controls, weighting each sample by the number of prior attempts to prioritize epigenetic changes associated with recurrent suicidal behavior. Combined with iterative random sampling to retain only markers reproducible across sample compositions, this approach identified 365 CpG sites enriched in neurobiological pathways such as dopaminergic synapses and dendritic spines rather than inflammatory processes. Consistent with the underlying hypothesis, 28 of these sites showed methylation levels that scaled with attempt frequency, mapping to genes governing circadian regulation ( CLOCK ), synaptic remodeling ( MMP9 ), and serine biosynthesis ( PHGDH ). The marker panel achieved consistent classification (AUROC 0.733 to 0.760) across three independent cohorts of Korean blood, UK postmortem brain, and Lithuanian blood. The NEK4 - ITIH1 locus ranked as the top marker in both blood and brain and showed suicidality-associated methylation changes across all cohorts. This locus lies within 3p21.1, a robustly replicated risk region for bipolar disorder in which genetic variation has been directly associated with suicide attempt, and NEK4 itself regulates dendritic spine density and circadian emotional behavior. These findings identify NEK4 - ITIH1 locus as a cross-tissue epigenetic marker of suicidality detectable in peripheral blood.
- 25 September 2026
- Published by Springer Nature in Research Square
Open AccessEpigenetic signatures of recurrent suicide attempts with cross-ethnic and cross-tissue validation highlight the NEK4-ITIH1 locus
Suicide is a major public health concern, yet objective biological markers for risk assessment remain lacking. Prior blood-based epigenomic studies have largely returned immune-related signals of uncertain specificity to suicidality. Here, we performed differential methylation analysis on whole blood from 69 Korean suicide attempters and 207 matched controls, weighting each sample by the number of prior attempts to prioritize epigenetic changes associated with recurrent suicidal behavior. Combined with iterative random sampling to retain only markers reproducible across sample compositions, this approach identified 365 CpG sites enriched in neurobiological pathways such as dopaminergic synapses and dendritic spines rather than inflammatory processes. Consistent with the underlying hypothesis, 28 of these sites showed methylation levels that scaled with attempt frequency, mapping to genes governing circadian regulation ( CLOCK ), synaptic remodeling ( MMP9 ), and serine biosynthesis ( PHGDH ). The marker panel achieved consistent classification (AUROC 0.733 to 0.760) across three independent cohorts of Korean blood, UK postmortem brain, and Lithuanian blood. The NEK4 - ITIH1 locus ranked as the top marker in both blood and brain and showed suicidality-associated methylation changes across all cohorts. This locus lies within 3p21.1, a robustly replicated risk region for bipolar disorder in which genetic variation has been directly associated with suicide attempt, and NEK4 itself regulates dendritic spine density and circadian emotional behavior. These findings identify NEK4 - ITIH1 locus as a cross-tissue epigenetic marker of suicidality detectable in peripheral blood.
- Open Access
- 26 April 2024
- Published by Elsevier in Comprehensive Psychoneuroendocrinology
- Vol. 19, 100235
Higher levels of plasma Adrenocorticotropic hormone (ACTH) are associated with lower suicidal ideation in depressed patients compared to controls and suicide attempters, independently from depression severity
- 26 April 2024
- Published by Elsevier in Comprehensive Psychoneuroendocrinology
- Vol. 19, 100235
Open AccessHigher levels of plasma Adrenocorticotropic hormone (ACTH) are associated with lower suicidal ideation in depressed patients compared to controls and suicide attempters, independently from depression severity
- 21 February 2017
- Published by Morressier GmbH
Poor CYP2D6 and Ultrarapid CYP2C19 Metabolizer: Clinical Challenge in Psychiatric Treatment
- 21 February 2017
- Published by Morressier GmbH
Poor CYP2D6 and Ultrarapid CYP2C19 Metabolizer: Clinical Challenge in Psychiatric Treatment